 |
|
|
|
|
Beteiligte Max-Planck-Institute |
|
MPI für Immunbiologie |
|
|
Autoren |
|
Lampugnani, M. G.; Zanetti, A.; Corada, M.; Takahashi, T.; Balconi, G.; Breviario, F.; Orsenigo, F.; Cattelino, A.; Kemler, R.; Daniel, T. O.; Dejana, E.; |
|
|
Publikationstyp |
|
Artikel |
|
|
Titel |
|
Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148 |
|
|
Zusammenfassung |
|
Confluent endothelial cells respond poorly to the proliferative signals of VEGF. Comparing isogenic endothelial cells differing for vascular endothelial cadherin (VE-cadherin) expression only, we found that the presence of this protein attenuates VEGF-induced VEGF receptor (VEGFR) 2 phosphorylation in tyrosine, p44/p42 MAP kinase phosphorylation, and cell proliferation. VE-cadherin truncated in β-catenin but not p120 binding domain is unable to associate with VEGFR-2 and to induce its inactivation. β-Catenin-null endothelial cells are not contact inhibited by VE-cadherin and are still responsive to VEGF, indicating that this protein is required to restrain growth factor signaling. A dominant-negative mutant of high cell density-enhanced PTP 1 (DEP-1)//CD148 as well as reduction of its expression by RNA interference partially restore VEGFR-2 phosphorylation and MAP kinase activation. Overall the data indicate that VE-cadherin-β-catenin complex participates in contact inhibition of VEGF signaling. Upon stimulation with VEGF, VEGFR-2 associates with the complex and concentrates at cell-cell contacts, where it may be inactivated by junctional phosphatases such as DEP-1. In sparse cells or in VE-cadherin-null cells, this phenomenon cannot occur and the receptor is fully activated by the growth factor. |
|
|
Quelle |
|
Journal of Cell Biology 161 (4), 793-804 (2003) |
|
|
Sprache |
|
English |
|
|
Identifikation |
|
ISI 000183286700015
ISSN 0021-9525 |
|
|
|
|
|
|
© 2009, Max-Planck-Gesellschaft, München |
|
|
